|

Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative

RECRUITINGN/ASponsored by University of Colorado, Denver
Actively Recruiting
PhaseN/A
SponsorUniversity of Colorado, Denver
Started2026-10-02
Est. completion2027-07
Eligibility
Age10 Years – 20 Years
Healthy vol.Accepted
Locations1 site

Summary

This study plans to learn more about whether a support program delivered in Spanish or both English and Spanish for bilingual families helps Latino youth with Type 1 Diabetes (T1D) successfully use the Medtronic MiniMed 780G system. The main question it aims to answer is: Does a linguistically and culturally tailored onboarding model for an automated insulin delivery system close the gap in technology adoption and improve health outcomes? Participants will: * Use the Medtronic MiniMed 780G Automated Insulin Delivery system for eight months * Attend one in-person nutrition support and insulin pump start class * Participate in regular virtual check-ins with native Spanish-speaking study team members

Eligibility

Age: 10 Years – 20 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 10 - 20 years old
* Diagnosis of type 1 diabetes
* Self-identify as Latino/Hispanic (determined via self-report and/or electronic health record)
* Currently managing diabetes using any regimen, including multiple daily injections (MDI) or any non-Medtronic automated insulin delivery system
* Willing to transition to and use the Medtronic MiniMed 780G system for the duration of the study

Exclusion Criteria:

* Current use of any Medtronic technology
* More than 1 episode of diabetic ketoacidosis (DKA) within 12 months of study enrollment
* Current pregnancy (self-reported), due to limited safety data for use of the Medtronic MiniMed 780G system during pregnancy
* Presence of any significant medical condition that, in the opinion of the investigator, would interfere with study participation or data interpretation
* Inability or unwillingness to use the Medtronic MiniMed 780G system for the duration of the study

Conditions2

DiabetesDiabetes Mellitus, Type 1 Diabetes

Locations1 site

Barbara Davis Center
Aurora, Colorado, 80045
Study Coordinator303-724-4315Karen.Hernandez@cuanschutz.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.